Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury
Authors:
Open Access
- 1 July 2015
- journal article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 8, 1701-1706
Abstract
Background/aim: To elucidate the mechanism responsible for developing acute kidney injury in patients with diabetes mellitus, we also evaluated the issue of whether advanced glycation endproducts (AGEs) influence the expressions of multi antimicrobial extrusion protein (MATE1/SLC47A1) in tubular cells. Materials and methods: To detect changing expression of MATE1/SLC47A1 in dose- and time-dependent manners, human proximal tubular epithelial cells were incubated with AGE-aggregated-human serum albumin. As a function assay for MATE1/SLC47A1, human proximal tubular epithelial cells were incubated with cisplatin or carboplatin. Results: On incubation with AGEs, the expressions of MATE1/SLC47A1 were decreased in tubular cells. In addition, the toxicities of cisplatin were increased in tubular cells that had been pretreated with AGEs. However, the toxicities of carboplatin were smaller than that of cisplatin in proximal tubular epithelial cells. Conclusion: The expression of the MATE1/SLC47A1 is decreased by AGEs, which increases the risk for proximal tubular injury.Keywords
This publication has 33 references indexed in Scilit:
- Advanced Glycation Endproducts Stimulate Renal Epithelial Cells to Release Chemokines That Recruit Macrophages, Leading to Renal FibrosisBioscience, Biotechnology, and Biochemistry, 2012
- Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathwayEuropean Journal of Pharmacology, 2011
- Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agentsBiochemical Pharmacology, 2011
- Advanced glycation end products‐induced apoptosis attenuated by PPARδ activation and epigallocatechin gallate through NF‐κB pathway in human embryonic kidney cells and human mesangial cellsDiabetes/Metabolism Research and Reviews, 2010
- Altered Pharmacokinetics of Cationic Drugs Caused by Down-Regulation of Renal Rat Organic Cation Transporter 2 (Slc22a2) and Rat Multidrug and Toxin Extrusion 1 (Slc47a1) in Ischemia/Reperfusion-Induced Acute Kidney InjuryDrug Metabolism and Disposition, 2008
- Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure ratsBiochemical Pharmacology, 2007
- Carbonyl Stress and Diabetic ComplicationsClinical Chemistry and Laboratory Medicine (CCLM), 2003
- Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant StressJournal of Biological Chemistry, 1997
- The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.Journal of Clinical Investigation, 1996
- Acute Renal FailureNew England Journal of Medicine, 1996